Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

Editorial

Thursday, March 21, 2013

Welcome to the March Issue of Private Equity Strategies. In this issue we’re going to look at the potential symbolic and real effects when large institutions like pensions and endowments divest.

In our Dealmakers Q&A we will speak with Jim Butterfield of the Riverside Company to learn more how they shrink their funnel from 4000 opportunities to the 20-30 deals they make each year. Butterfield will also take us through their recent Baby Jogger transaction to learn about what set that portfolio company apart in the deal making process.

In Regs Watch, Jay Gould of the law firm Pillsbury has contributed a piece about the recent enforcement action the SEC took against Oppenheimer’s private equity group and what it may mean for private equity firms now that they are coming under closer scrutiny from the regulator. We will also highlight other recent regulatory changes to put on the radar.

In our Data Snapshot, we discuss the growing institutional appetite for the IPO market with Maria Pinelli, Global Vice Chair of Strategic Growth Markets at Ernst & Young, which recently surveyed a number of institutions to find out why IPOs may heat up this year.

In our Movers and Shakers section, law firm Nixon Peabody contributes an update on a potential new investment area for private equity firms in New York State.

As always, Quick Hits will have a round up of fund news and events.

I welcome your feedback and hope you will continue to reach out to me about our coverage and where we might go next.

Sincerely,

Bailey McCann

Editor

mccann@opalesque.com

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its